Mr. Neville is CEO of Savara. Prior to co-founding Savara, Mr. Neville was founder and CEO of the Austin Technology Incubator-based Evity, Inc., which was acquired by BMC in 2000 for $100M based on a single round of angel funding (40x ROI in 18 moinths).

Dr. Jouhikainen is Head of Product Development for Savara responsible for product and platform development. He is a veteran executive in the medical and pharmaceutical industries. During his career, Dr. Jouhikainen has held executive positions with several companies including Interim CEO and Senior Vice President of Product Development at Akela Pharma Inc., President and CEO at Focus Inhalation, Chairman of the Board at Spectrum Medical Sciences.

Dr. Lord is Head of Pharmaceutical Development at Savara and is responsible for all CMC activities. He has over seventeen years of inhalation product development experience working on products ranging from early formulation to commercial. His experience includes leadership roles at numerous pharmaceutical companies including Rhône-Poulenc Rorer and Nektar Therapeutics, with a focus on pharmaceutical development of inhalation products.

Mr. Marich is Head of Business Operations and co-founder of Savara. He has significant experience managing the financial and logistical components of large multi-team projects across numerous industries and geographies including enterprise software and pharmaceutical product development. As co-founder of numerous companies from idea to successful exit, including one to a Fortune 1000 company.